Ruth O'Gorman Tuura1,2,3,4, Walter Knirsch5,6,7, Céline Steger1,8,2,3,4, Maria Feldmann2,3,4,9, Julia Borns8,2,10, Cornelia Hagmann2,4,11, Beatrice Latal2,4,9, Ulrike Held4,12, András Jakab1,2,3,4. 1. Center for MR-Research, University Children's Hospital, Zurich, Switzerland. 2. Children's Research Center, University Children's Hospital, Zürich, Switzerland. 3. Neuroscience Center Zürich, University of Zürich, Zürich, Switzerland. 4. University of Zurich, Zurich, Switzerland. 5. Pediatric Cardiology, Pediatric Heart Center, Department of Surgery, University Children's Hospital, Zürich, Switzerland. walter.knirsch@kispi.uzh.ch. 6. Children's Research Center, University Children's Hospital, Zürich, Switzerland. walter.knirsch@kispi.uzh.ch. 7. University of Zurich, Zurich, Switzerland. walter.knirsch@kispi.uzh.ch. 8. Pediatric Cardiology, Pediatric Heart Center, Department of Surgery, University Children's Hospital, Zürich, Switzerland. 9. Child Development Center, University Children's Hospital, Zurich, Switzerland. 10. Pediatric Cardiology, Inselspital Bern, Bern, Switzerland. 11. Department of Neonatology and Pediatric Intensive Care, University Children's Hospital, Zurich, Switzerland. 12. Department of Epidemiology, Biostatistics and Prevention Institute UZH, Zürich, Switzerland.
Abstract
BACKGROUND: Altered neurometabolite ratios in neonates undergoing cardiac surgery for congenital heart defects (CHD) may serve as a biomarker for altered brain development and neurodevelopment (ND). METHODS: We analyzed single voxel 3T PRESS H1-MRS data, acquired unilaterally in the left basal ganglia and white matter of 88 CHD neonates before and/or after neonatal cardiac surgery and 30 healthy controls. Metabolite ratios to Creatine (Cr) included glutamate (Glu/Cr), myo-Inositol (mI/Cr), glutamate and glutamine (Glx/Cr), and lactate (Lac/Cr). In addition, the developmental marker N-acetylaspartate to choline (NAA/Cho) was evaluated. All children underwent ND outcome testing using the Bayley Scales of Infant and Toddler Development Third Edition (BSID-III) at 1 year of age. RESULTS: White matter NAA/Cho ratios were lower in CHD neonates compared to healthy controls (group beta estimate: -0.26, std. error 0.07, 95% CI: -0.40 - 0.13, p value <0.001, FDR corrected p value = 0.010). We found no correlation between pre- or postoperative white matter NAA/Cho with ND outcome while controlling for socioeconomic status and CHD diagnosis. CONCLUSION: Reduced white matter NAA/Cho in CHD neonates undergoing cardiac surgery may reflect a delay in brain maturation. Further long-term MRS studies are needed to improve our understanding of the clinical impact of altered metabolites on brain development and outcome. IMPACT: NAA/Cho was reduced in the white matter, but not the gray matter of CHD neonates compared to healthy controls. No correlation to the 1-year neurodevelopmental outcome (Bayley-III) was found. While the rapid change of NAA/Cho with age might make it a sensitive marker for a delay in brain maturation, the relationship to neurodevelopmental outcome requires further investigation.
BACKGROUND: Altered neurometabolite ratios in neonates undergoing cardiac surgery for congenital heart defects (CHD) may serve as a biomarker for altered brain development and neurodevelopment (ND). METHODS: We analyzed single voxel 3T PRESS H1-MRS data, acquired unilaterally in the left basal ganglia and white matter of 88 CHD neonates before and/or after neonatal cardiac surgery and 30 healthy controls. Metabolite ratios to Creatine (Cr) included glutamate (Glu/Cr), myo-Inositol (mI/Cr), glutamate and glutamine (Glx/Cr), and lactate (Lac/Cr). In addition, the developmental marker N-acetylaspartate to choline (NAA/Cho) was evaluated. All children underwent ND outcome testing using the Bayley Scales of Infant and Toddler Development Third Edition (BSID-III) at 1 year of age. RESULTS: White matter NAA/Cho ratios were lower in CHD neonates compared to healthy controls (group beta estimate: -0.26, std. error 0.07, 95% CI: -0.40 - 0.13, p value <0.001, FDR corrected p value = 0.010). We found no correlation between pre- or postoperative white matter NAA/Cho with ND outcome while controlling for socioeconomic status and CHD diagnosis. CONCLUSION: Reduced white matter NAA/Cho in CHD neonates undergoing cardiac surgery may reflect a delay in brain maturation. Further long-term MRS studies are needed to improve our understanding of the clinical impact of altered metabolites on brain development and outcome. IMPACT: NAA/Cho was reduced in the white matter, but not the gray matter of CHD neonates compared to healthy controls. No correlation to the 1-year neurodevelopmental outcome (Bayley-III) was found. While the rapid change of NAA/Cho with age might make it a sensitive marker for a delay in brain maturation, the relationship to neurodevelopmental outcome requires further investigation.
Authors: Denise van der Linde; Elisabeth E M Konings; Maarten A Slager; Maarten Witsenburg; Willem A Helbing; Johanna J M Takkenberg; Jolien W Roos-Hesselink Journal: J Am Coll Cardiol Date: 2011-11-15 Impact factor: 24.094
Authors: Nathalie H P Claessens; Pim Moeskops; Andreas Buchmann; Beatrice Latal; Walter Knirsch; Ianina Scheer; Ivana Išgum; Linda S de Vries; Manon J N L Benders; Michael von Rhein Journal: Pediatr Res Date: 2016-07-19 Impact factor: 3.756
Authors: Nathalie H P Claessens; Selma O Algra; Tom L Ouwehand; Nicolaas J G Jansen; Renske Schappin; Felix Haas; Maria J C Eijsermans; Linda S de Vries; Manon J N L Benders Journal: Dev Med Child Neurol Date: 2018-03-24 Impact factor: 5.449
Authors: Cynthia M Ortinau; Caitlin K Rollins; Anjali Sadhwani; David Wypij; Valerie Rofeberg; Ali Gholipour; Maggie Mittleman; Julia Rohde; Clemente Velasco-Annis; Johanna Calderon; Kevin G Friedman; Wayne Tworetzky; P Ellen Grant; Janet S Soul; Simon K Warfield; Jane W Newburger Journal: Circulation Date: 2022-02-10 Impact factor: 29.690
Authors: Ting Guo; Vann Chau; Shabnam Peyvandi; Beatrice Latal; Patrick S McQuillen; Walter Knirsch; Anne Synnes; Maria Feldmann; Nadja Naef; M Mallar Chakravarty; Alessandra De Petrillo; Emma G Duerden; A James Barkovich; Steven P Miller Journal: Neuroimage Date: 2018-06-15 Impact factor: 6.556
Authors: Daniel J Licht; David M Shera; Robert R Clancy; Gil Wernovsky; Lisa M Montenegro; Susan C Nicolson; Robert A Zimmerman; Thomas L Spray; J William Gaynor; Arastoo Vossough Journal: J Thorac Cardiovasc Surg Date: 2009-03 Impact factor: 5.209
Authors: Christopher J Kelly; Sophie Arulkumaran; Catarina Tristão Pereira; Lucilio Cordero-Grande; Emer J Hughes; Rui Pedro A G Teixeira; Johannes K Steinweg; Suresh Victor; Kuberan Pushparajah; Joseph V Hajnal; John Simpson; A David Edwards; Mary A Rutherford; Serena J Counsell Journal: Arch Dis Child Date: 2019-06-26 Impact factor: 3.791